IXICO plc announced the appointment of Lammert Albers as Chief Business Officer effective immediately. With a deep expertise of the Alzheimer's disease (AD) trials market, he will be responsible for executing the company's global business development strategy in both existing and new markets. Based in the US, Lammert will have responsibility for global business development, with a particular focus in driving international growth in North America & Asia.